Advanced Biomanufacturing of Therapeutic Cells (ABTC)

Advanced Biomanufacturing of Therapeutic Cells (ABTC) Full Proposal Deadline Date: April 17, 2017 Invited Proposal Deadline Program Guidelines: NSF 17-502   In recent years, somatic cells as therapeutic agents have provided new treatment approaches for a number of pathological conditions that were deemed untreatable, or difficult to treat. Several successful cell therapies using T cells have been demonstrated for cancer and autoimmune diseases, while stem cell therapies have given relief for heart disease and stroke. Hundreds of clinical trials are ongoing to examine efficacy of cell therapies for a variety of other diseases including diabetes, ... More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505376&WT.mc_id=USNSF_44&WT.mc_ev=click This is an NSF Upcoming Due Dates - Engineering item.   Follow NSF:    Save This email was sent using GovDelivery, on behalf of: National Science Foundation Update · 4201 Wilson Boulevard · Arlington, VA 22230 · 703-292-5111